The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country.

During the past decade, The University of Texas - MD Anderson Cancer Center - Infectious Diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" are "Cytomegalovirus Infection" (1 trials), "Influenza" (1 trials) and "Staphylococcal Bacteraemia" (1 trials). Many other conditions were trialed in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" in a lesser frequency.

Most popular intervention types in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" are "Biological" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cefazolin" (1 trials), "DBS Self-Collection Kit" (1 trials), "Dalbavancin" (1 trials), "Daptomycin" (1 trials) and "Nafcillin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" are 3 trials for "All" genders.

Currently, there are NaN active trials in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The University of Texas - MD Anderson Cancer Center - Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The University of Texas - MD Anderson Cancer Center - Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".